Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas.
about
Pancreatic cancer surgery and nutrition management: a review of the current literatureCan Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients.Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells.Identification of prognostic inflammatory factors in colorectal liver metastases.The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome StudyChronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer.Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive modelPrognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic reviewThe relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancerEarly hyperlactatemia predicts pancreatic fistula after surgerySystemic neutrophil-to-lymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour.Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and MetastasisCXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.Stromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice.Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies.Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinomaDownregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies.Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer.Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial.The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder.The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer.An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer.Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer.Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing.An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer.Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients.Postdiagnosis C-reactive protein and breast cancer survivorship: findings from the WHEL studyPreoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer.Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC)A Nomogram based on Inflammatory Factors C-Reactive Protein and Fibrinogen to Predict the Prognostic Value in Patients with Resected Non-Small Cell Lung CancerFive-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective.Preoperative Platelet-Lymphocyte Ratio Augments CA 19-9 as a Predictor of Malignancy in Chronic Calcific Pancreatitis.A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma.Predictive factors in pancreatic ductal adenocarcinoma: role of the inflammatory response.Glasgow prognostic score predicts therapeutic outcome after hepatic resection for hepatocellular carcinomaThrombocytosis of Liver Metastasis from Colorectal Cancer as Predictive Factor.Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: a randomized, double-blind clinical trial.Role of macrophages in malignancyThe glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
P2860
Q26864279-0A2FEB36-A37F-433E-9296-64A98B05D932Q28066454-4321BE0F-D897-436A-A9A4-789660C1EC4BQ33624392-1CA80C03-79E5-4BF4-BB90-64B168469780Q33945484-D77A0DC8-DD74-489E-8C8A-2F8DBECDE3CAQ34017917-A8F28A72-0A58-43BF-80ED-6644339E87DAQ34253740-F0C90B42-C61B-4120-B21C-668BDF3F63A6Q34346758-0514E362-B722-4791-AB74-D8A84999F3E2Q35128731-85FB4E94-B328-491C-9CDF-0F6558C0E656Q35202177-98834C27-DFF6-42C9-9ED9-15EFD145D6E5Q35551037-C92FBE7C-802E-473E-AB0C-2192FFE0A4DFQ35717616-14663E77-27F5-466A-87DF-2B2C65C0B079Q35863187-74BC0A95-16C7-46A3-91DD-A6DC4495520AQ35922334-F4B05321-E22D-43E7-A406-0D6E165A88ECQ36041701-DE21198C-84B6-47B1-AD45-5B3C1F654AE0Q36143628-ED80CC16-910E-41D9-91FD-BEC3EBBE9F4CQ36390825-049CCC76-E9CE-4243-800C-01F6B9D97008Q36408348-4E5833AD-EC2D-4CC4-9840-78CF6E3AD551Q36608759-622D9300-EF7C-4963-8886-2C3AE065A837Q36610116-0FEA4BEB-5BDB-40B1-BDF2-FF16B4958AAAQ36611097-22E1518C-21FA-4B02-BAE5-41F9B2CCCAC4Q36611805-68729711-0A3C-4CC5-8DD8-DEA4E2919360Q36612383-CB4FB028-F8F4-4FBE-8B76-34884F7C9FC3Q36614306-036618B9-53D8-4FAF-B5A0-265BA53CCA58Q37003283-CF711B68-0C3F-45CE-8104-29B6753217CEQ37076331-7F346C62-615E-4A32-932B-3B72A30A9730Q37152934-2CB7387D-5930-4098-BFDB-0B6D1726FD0FQ37459643-152664FF-785B-459B-B815-9423BBB5DEFEQ37548324-47C9FA2C-0FE0-494A-8887-9E78008D7F58Q37639239-D69436B9-B304-442F-AE2A-D7D3189DB71BQ37687561-D541E19C-FF97-4B6F-B0AA-CEA9BA498BF2Q37738071-8B492C3B-7632-46D1-867F-6610F6AEF450Q39039179-E9A91AF3-64DD-4490-8C12-469030E58078Q39381682-22FDD275-EF40-41D0-AC6C-8B4D44A7364BQ39789698-1B431024-B749-4455-A090-B0E8AE86E33DQ40212563-70581AF2-913A-4690-A44E-8239124AEA48Q40978049-A5A54AA0-E5AC-4D3F-861C-11DA46BDEB25Q41243228-CCB57151-FB60-4BD8-929C-EAA471E8E46AQ41389781-542E4654-AD9F-458F-9C1C-DDBC8F84A801Q41488368-3A00C37B-837E-4914-8E6F-70EA78CEC17CQ43459107-0A0555AB-E062-4D35-AE7E-8FC283C6E80C
P2860
Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Systemic inflammatory response ...... enocarcinoma head of pancreas.
@ast
Systemic inflammatory response ...... enocarcinoma head of pancreas.
@en
type
label
Systemic inflammatory response ...... enocarcinoma head of pancreas.
@ast
Systemic inflammatory response ...... enocarcinoma head of pancreas.
@en
prefLabel
Systemic inflammatory response ...... enocarcinoma head of pancreas.
@ast
Systemic inflammatory response ...... enocarcinoma head of pancreas.
@en
P2093
P2860
P921
P356
P1476
Systemic inflammatory response ...... denocarcinoma head of pancreas
@en
P2093
P2860
P2888
P356
10.1038/SJ.BJC.6602305
P407
P577
2005-01-01T00:00:00Z